Human Genetics

, Volume 120, Issue 1, pp 22–30 | Cite as

Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia



A number of studies have suggested an association between schizophrenia and the tryptophan hydroxylase (TPH) and tyrosine hydroxylase (TH) genes. On the other hand, several studies attempting to replicate these findings have produced mixed results, possibly reflecting inadequate statistical power of the individual studies as well as the heterogeneity inherent in schizophrenia. In an attempt to clarify this inconsistency our meta-analysis has combined all the studies using multiple research methods published up to February 2006 to give a comprehensive picture of the role of three hydroxylase-related genes. The TPH A218C/A779C (OR = 1.18, 95% C.I. 1.06–1.33, P = 0.004) revealed a significant association with schizophrenia. However, the evidence for the TH and phenylalanine hydroxylase (PAH) genes was weak. No publication bias was detected in current studies. The findings, which may implicate the involvement of TPH in the pathogenesis of schizophrenia, have potentially important clinical, scientific and public health implications as well as providing a putative basis for the study of hydroxylase-related drugs. To our knowledge, this is the first meta-analysis of association between the three genes and schizophrenia.

Supplementary material

439_2006_190_MOESM1_ESM.pdf (953 kb)
Supplementary material


  1. Abbar M, Courtet P, Bellivier F, Leboyer M, Boulenger JP, Castelhau D, Ferreira M, Lambercy C, Mouthon D, Paoloni-Giacobino A, Vessaz M, Malafosse A, Buresi C (2001) Suicide attempts and the tryptophan hydroxylase gene. Mol Psychiatry 6:268–273PubMedCrossRefGoogle Scholar
  2. Anney RJ, Olsson CA, Lotfi-Miri M, Patton GC, Williamson R (2004) Nicotine dependence in a prospective population-based study of adolescents: the protective role of a functional tyrosine hydroxylase polymorphism. Pharmacogenetics 14:73–81PubMedCrossRefGoogle Scholar
  3. Arango V, Huang YY, Underwood MD, Mann JJ (2003) Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 37:375–386PubMedCrossRefGoogle Scholar
  4. Bjur RA, Weiner N (1975) The activity of tyrosine hydroxylase in intact adrenergic neurons of the mouse vas deferens. J Pharmacol Exp Ther 194:9–26PubMedGoogle Scholar
  5. Boularand S, Darmon MC, Mallet J (1995) The human tryptophan hydroxylase gene. An unusual splicing complexity in the 5′-untranslated region. J Biol Chem 270:3748–3756PubMedCrossRefGoogle Scholar
  6. Burgert E, Crocq MA, Bausch E, Macher JP, Morris-Rosendahl DJ (1998) No association between the tyrosine hydroxylase microsatellite marker HUMTH01 and schizophrenia or bipolar I disorder. Psychiatr Genet 8:45–48PubMedCrossRefGoogle Scholar
  7. Chao HM, Richardson MA (2002) Aromatic amino acid hydroxylase genes and schizophrenia. Am J Med Genet 114:626–30PubMedCrossRefGoogle Scholar
  8. Chotai J, Serretti A, Lattuada E, Lorenzi C, Lilli R (2003) Gene-environment interaction in psychiatric disorders as indicated by season of birth variations in tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine receptor (DRD4) gene polymorphisms. Psychiatry Res 119:99–111PubMedCrossRefGoogle Scholar
  9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  10. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMedGoogle Scholar
  11. Ekwall O, Hedstrand H, Haavik J, Perheentupa J, Betterle C, Gustafsson J, Husebye E, Rorsman F, Kampe O (2000) Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 85:2944–2950PubMedCrossRefGoogle Scholar
  12. Hong CJ, Tsai SJ, Wang YC (2001) Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders. Schizophr Res 49:59–63PubMedCrossRefGoogle Scholar
  13. Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ (2005) No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am J Med Genet B Neuropsychiatr Genet 134:6–9Google Scholar
  14. Hufton SE, Jennings IG, Cotton RG (1995) Structure and function of the aromatic amino acid hydroxylases. Biochem J 311(Pt 2):353–366PubMedGoogle Scholar
  15. Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shiozuka S, Hamaguchi H, Toru M, Shibuya H (1998) Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism. Am J Med Genet 81:388–396PubMedCrossRefGoogle Scholar
  16. Iwata Y, Matsumoto H, Minabe Y, Osada N, Nakamura K, Sekizawa T, Suzuki K, Sekine Y, Takei N, Mori N (2003) Early-onset schizophrenia and dopamine-related gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 116:23–26CrossRefGoogle Scholar
  17. Jonsson E, Brene S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G (1996) A search for association between schizophrenia and dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci 246:297–304PubMedCrossRefGoogle Scholar
  18. Jonsson EG, Geijer T, Gyllander A, Terenius L, Sedvall GC (1998) Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia. Eur Arch Psychiatry Clin Neurosci 248:61–63PubMedCrossRefGoogle Scholar
  19. Kleppe R, Haavik J (2004) Different stabilities and denaturation pathways for structurally related aromatic amino acid hydroxylases. FEBS Lett 565:155–159PubMedCrossRefGoogle Scholar
  20. Kunugi H, Kawada Y, Hattori M, Ueki A, Otsuka M, Nanko S (1998) Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson’s disease. Am J Med Genet 81:131–133PubMedCrossRefGoogle Scholar
  21. Kunugi H, Ishida S, Kato T, Sakai T, Tatsumi M, Hirose T, Nanko S (1999) No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 156:774–776PubMedGoogle Scholar
  22. Kurumaji A, Kuroda T, Yamada K, Yoshikawa T, Toru M (2001) An association of the polymorphic repeat of tetranucleotide (TCAT) in the first intron of the human tyrosine hydroxylase gene with schizophrenia in a Japanese sample. J Neural Transm 108:489–495PubMedCrossRefGoogle Scholar
  23. Li D, He L (2006) Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum Genet 19(3):233–240CrossRefGoogle Scholar
  24. Martinez A, Knappskog PM, Haavik J (2001) A structural approach into human tryptophan hydroxylase and its implications for the regulation of serotonin biosynthesis. Curr Med Chem 8:1077–1091PubMedGoogle Scholar
  25. Meloni R, Laurent C, Campion D, Ben Hadjali B, Thibaut F, Dollfus S, Petit M, Samolyk D, Martinez M, Poirier MF et al (1995) A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C R Acad Sci III 318:803–809PubMedGoogle Scholar
  26. Meloni R, Biguet NF, Mallet J (2002) Post-genomic era and gene discovery for psychiatric diseases: there is a new art of the trade? The example of the HUMTH01 microsatellite in the Tyrosine Hydroxylase gene. Mol Neurobiol 26:389–403PubMedCrossRefGoogle Scholar
  27. Nagatsu T (1995) Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology. Essays Biochem 30:15–35PubMedGoogle Scholar
  28. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997) Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Brain Res Mol Brain Res 45:145–148PubMedCrossRefGoogle Scholar
  29. Nolan KA, Volavka J, Lachman HM, Saito T (2000) An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder. Psychiatr Genet 10:109–15PubMedGoogle Scholar
  30. O’Malley KL, Anhalt MJ, Martin BM, Kelsoe JR, Winfield SL, Ginns EI (1987) Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5′ alternative splice sites responsible for multiple mRNAs. Biochemistry 26:6910–6914PubMedCrossRefGoogle Scholar
  31. Ota M, Nakashima A, Ikemoto K, Nojima S, Tanaka M, Okuda M, Koga H, Mori K, Kaneko YS, Fujiwara K, Yamamoto H, Nagatsu T, Ota A (2001) Exon 3 of tyrosine hydroxylase gene: lack of association with Japanese schizophrenic patients. Mol Psychiatry 6:315–319PubMedCrossRefGoogle Scholar
  32. Pae CU, Kim JJ, Serretti A, Lee CU, Lee SJ, Lee C, Paik IH (2003) VNTR polymorphism of tyrosine hydroxylase gene and schizophrenia in the Korean population. Neuropsychobiology 47:131–136PubMedCrossRefGoogle Scholar
  33. Paik I, Toh K, Kim J, Lee C (2000) TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Hum Hered 50:365–369PubMedCrossRefGoogle Scholar
  34. Paoloni-Giacobino A, Mouthon D, Lambercy C, Vessaz M, Coutant-Zimmerli S, Rudolph W, Malafosse A, Buresi C (2000) Identification and analysis of new sequence variants in the human tryptophan hydroxylase (TpH) gene. Mol Psychiatry 5:49–55PubMedCrossRefGoogle Scholar
  35. Polymeropoulos MH, Xiao H, Rath DS, Merril CR (1991) Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 19:3753Google Scholar
  36. Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonkar VL, Thelma BK (2002) Molecular genetics of schizophrenia: past, present and future. J Biosci 27:35–52PubMedCrossRefGoogle Scholar
  37. Richardson MA, Read LL, Clelland JD, Chao HM, Reilly MA, Romstad A, Suckow RF (2003) Phenylalanine hydroxylase gene in psychiatric patients: screening and functional assay of mutations. Biol Psychiatry 53:543–553PubMedCrossRefGoogle Scholar
  38. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M, Goldman D, Nielsen D (1999) Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 4:360–368PubMedCrossRefGoogle Scholar
  39. Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M, Yakir A, Greenberg D, Strous R, Lerner A, Shelevoy A, Lerer B (2003) Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics J 3:277–283PubMedCrossRefGoogle Scholar
  40. Sekizawa T, Iwata Y, Nakamura K, Matsumoto H, Suzuki A, Suzuki K, Sekine Y, Takei N, Minabe Y, Mori N (2004) Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 128:24–26CrossRefGoogle Scholar
  41. Semwal P, Prasad S, Bhatia T, Deshpande SN, Wood J, Nimgaonkar VL, Thelma BK (2001) Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol Psychiatry 6:220–224PubMedCrossRefGoogle Scholar
  42. Semwal P, Prasad S, Varma PG, Bhagwat AM, Deshpande SN, Thelma BK (2002) Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J Genet 81:65–71PubMedCrossRefGoogle Scholar
  43. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E (1999) Lack of association between tryptophan hydroxylase gene and psychotic symptomatology in schizophrenia. Schizophr Res 40:171–172PubMedCrossRefGoogle Scholar
  44. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E (2001) Tryptophan hydroxylase gene and major psychoses. Psychiatry Res 103:79–86PubMedCrossRefGoogle Scholar
  45. Shinkai T, Ohmori O, Suzuki T, Kojima H, Hori H, Terao T, Nakamura J (2000) Polymorphisms of tryptophan hydroxylase gene and the symptomatology of schizophrenia: an association study. Psychiatr Genet 10:165–171PubMedCrossRefGoogle Scholar
  46. Teigen K, Dao KK, McKinney JA, Gorren AC, Mayer B, Froystein NA, Haavik J, Martinez A (2004) Tetrahydrobiopterin binding to aromatic amino acid hydroxylases. Ligand recognition and specificity. J Med Chem 47:5962–5971PubMedCrossRefGoogle Scholar
  47. Thibaut F, Ribeyre JM, Dourmap N, Meloni R, Laurent C, Campion D, Menard JF, Dollfus S, Mallet J, Petit M (1997) Association of DNA polymorphism in the first intron of the tyrosine hydroxylase gene with disturbances of the catecholaminergic system in schizophrenia. Schizophr Res 23:259–264PubMedCrossRefGoogle Scholar
  48. Waters PJ, Parniak MA, Nowacki P, Scriver CR (1998) In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function. Hum Mutat 11:4–17PubMedCrossRefGoogle Scholar
  49. Wei J, Ramchand CN, Hemmings GP (1995) Association of polymorphic VNTR region in the first intron of the human TH gene with disturbances of the catecholamine pathway in schizophrenia. Psychiatr Genet 5:83–88PubMedCrossRefGoogle Scholar
  50. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251–253PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Bio-X CenterShanghai Jiao Tong UniversityShanghaiPeople’s Republic of China
  2. 2.Institute for Nutritional Sciences, Shanghai Institute of Biological Sciences (SIBS)Chinese Academy of SciencesShanghaiPeople’s Republic of China
  3. 3.NHGG Bio-X CenterShanghai Jiaotong UniversityShanghaiPeople’s Republic of China

Personalised recommendations